Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 2
2011 3
2012 1
2013 3
2014 1
2015 1
2016 1
2017 1
2018 3
2019 3
2020 4
2021 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
CRMP5 Antibodies-Diagnostic Challenges.
Totland C, Haugen M, Vedeler C. Totland C, et al. Front Neurol. 2021 Sep 22;12:729075. doi: 10.3389/fneur.2021.729075. eCollection 2021. Front Neurol. 2021. PMID: 34630302 Free PMC article.
CCDC104 Antibodies and Mitosis of Cancer Cells.
Eichler TW, Totland C, Haugen M, Vedeler CA. Eichler TW, et al. Among authors: totland c. Scand J Immunol. 2018 Feb;87(2):109-110. doi: 10.1111/sji.12634. Scand J Immunol. 2018. PMID: 29193323 Free article. No abstract available.
CDR2 antigen and Yo antibodies.
Totland C, Aarskog NK, Eichler TW, Haugen M, Nøstbakken JK, Monstad SE, Salvesen HB, Mørk S, Haukanes BI, Vedeler CA. Totland C, et al. Cancer Immunol Immunother. 2011 Feb;60(2):283-9. doi: 10.1007/s00262-010-0943-9. Epub 2010 Nov 16. Cancer Immunol Immunother. 2011. PMID: 21080165 Free PMC article.
Avidity of onconeural antibodies is of clinical relevance.
Totland C, Ying M, Haugen M, Mazengia K, Storstein A, Aarseth J, Martinez A, Vedeler C. Totland C, et al. Cancer Immunol Immunother. 2013 Aug;62(8):1393-6. doi: 10.1007/s00262-013-1442-6. Epub 2013 Jun 4. Cancer Immunol Immunother. 2013. PMID: 23733227
Hu and Yo antibodies have heterogeneous avidity.
Totland C, Aarseth J, Vedeler C. Totland C, et al. J Neuroimmunol. 2007 Apr;185(1-2):162-7. doi: 10.1016/j.jneuroim.2007.01.016. Epub 2007 Mar 2. J Neuroimmunol. 2007. PMID: 17336396
24 results